Knight Therapeutics | GUD - Ebitda

Preço das Ações
6.14
Mudança Diária
0.04 0.66%
Mensal
-4.06%
Anual
-0.49%
Q1 Previsão
5.95




Ebitda Alterar Data
Acasti Pharma USD -3.18M 521K 2025-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Aurora Cannabis CAD 15.37M 26.8M 2025-09
Avita Medical AUD -9.69M 12.21M 2025-12
Canopy Growth CAD 16.62M 38.45M 2025-09
Cronos Group USD 456K 5.22M 2025-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Knight Therapeutics CAD 20.99M 5.48M 2025-09
Moderna USD -790M 582M 2025-12
Omeros USD -47.96M 7.39M 2023-09
Organigram Holdings CAD 6.15M 455K 2025-09
Organon & Co USD 383M 135M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Tectonic Therapeutic USD -13.48M 5.73M 2024-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1B 151.5M 2025-12
Xeris Pharmaceuticals USD 17.42M 8.83M 2025-09